TRAXARA®

TRANEXAMIC ACID
TRAXARA®

Available Presentations:

  • INTRAVENOUS SOLUTION, 50 mg/mL
  • VIALS, 250 mg/5 mL
INN: tranexamic acid
Presentation: intravenous solution, 50 mg/mL
Vials, 250 mg/5 mL
ATC Group: B02AA02
Antifibrinolytic
Scope of Application: Treatment and prevention of disorders of blood coagulation — hemorrhages
Status of Administration: prescription only
VED Status: listed in VED List
Marketing Authorization: LP 002926
Shelf Life: 3 years
Conditions of Storage: store at or below 25°C, do not freeze

THE INFORMATION ON THIS PAGE IS NOT AN ADVERTISEMENT AND IS INTENDED TO INFORM ON THE PRODUCTS MANUFACTURED BY THE COMPANY.

THE MEDICINAL PRODUCTS HAVE CONTRAINDICATIONS, CONTACT YOUR DOCTOR.